Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Insider Changes in Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. 8-K Event Other events
  11. 424B5 Offering Prospectus
  12. 424B5 Offering Prospectus
  13. 8-K Event Results of operations · Other events
  14. 4 Option exercise President and CEO acquired 100,000 shares (option exercise)
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award EVP, Chief Development Officer acquired 3,101 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 930 shares (grant or award)

Page 19 of 41 · 801 filings